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Abstract
Background: Bacterial vaginosis (BV) is an ecological disorder of the vaginal microbiota that affects millions of
women annually, and is associated with numerous adverse health outcomes including pre-term birth and the
acquisition of sexually transmitted infections. However, little is known about the overall structure and composition
of vaginal microbial communities; most of the earlier studies focused on predominant vaginal bacteria in the
process of BV. In the present study, the diversity and richness of vaginal microbiota in 50 BV positive and
50 healthy women from China were investigated using culture-independent PCR-denaturing gradient gel
electrophoresis (DGGE) and barcoded 454 pyrosequencing methods, and validated by quantitative PCR.
Results: Our data demonstrated that there was a profound shift in the absolute and relative abundances of bacterial
species present in the vagina when comparing populations associated with healthy and diseased conditions. In spite
of significant interpersonal variations, the diversity of vaginal microbiota in the two groups could be clearly divided
into two clusters. A total of 246,359 high quality pyrosequencing reads was obtained for evaluating bacterial diversity
and 24,298 unique sequences represented all phylotypes. The most predominant phyla of bacteria identified in the
vagina belonged to Firmicutes, Bacteroidetes, Actinobacteria and Fusobacteria. The higher number of phylotypes in BV
positive women over healthy is consistent with the results of previous studies and a large number of low-abundance
taxa which were missed in previous studies were revealed. Although no single bacterium could be identified as a
specific marker for healthy over diseased conditions, three phyla - Bacteroidetes, Actinobacteria and Fusobacteria, and
eight genera including Gardnerella, Atopobium, Megasphaera, Eggerthella, Aerococcus, Leptotrichia/Sneathia, Prevotella
and Papillibacter were strongly associated with BV (p < 0.05). These genera are potentially excellent markers and
could be used as targets for clinical BV diagnosis by molecular approaches.
Conclusions: The data presented here have clearly profiled the overall structure of vaginal communities and
clearly demonstrated that BV is associated with a dramatic increase in the taxonomic richness and diversity of
vaginal microbiota. The study also provides the most comprehensive picture of the vaginal community structure
and the bacterial ecosystem, and significantly contributes to the current understanding of the etiology of BV.
Background
An enormous number of microorganisms, the vast
majority of which are bacterial species, are known to
colonize and form complex communities, or microbiota,
at various sites within and on the human body [1,2].
Microbial cells that thrive on and within the human
body are approximately 10 times more numerous than
our own cells and contain, in aggregate, about 100 times
more genes, leading to the suggestion that humans and
our microbial symbionts be considered “supraorganisms”
[3]. A growing body of evidence suggests that the com-
position and function of the microbiota in different
human body habitats plays a vital role in human devel-
opment, physiology, immunity, and nutrition [1,4-8]. As
one of the important human- microbial habitats, the
vagina harbors different species of bacteria in very large
numbers that are known to have important effects on
health [9]. Many of these bacteria such as hydrogen
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are not simply passive or transient colonizers, but rather
appear to be adapted to the specific environment of the
vagina [10-12]. These resident species effectively consti-
tute an ecological guild - a group of species that have
similar requirements and play a similar role within a
community - and maintaining high numbers of these
populations is a hallmark of healthy conditions [13].
The dramatic changes in the types and relative propor-
tions of the microbial species in the vagina could lead to
a diseased state [14]. One important component of the
Human Microbiome Project (HMP), states that it is
necessary to explore the bacterial diversity of vagina in
health and disease and to understand whether changes
in the vaginal microbiome can be correlated with
changes in human health [2].
BV is the most prevalent lower genital tract infection
in women of reproductive age throughout the world
[15-18]. It affects millions of women annually [19] and
is strongly associated with several adverse health out-
comes, including preterm labor and delivery [20,21], pel-
vic inflammatory disease [22], postpartum and
postabortal endometritis [23], and increased susceptibil-
ity to infection with various pathogens, such as Neisseria
gonorrhoeae, Trichomonas vaginalis, Chlamydia tracho-
matis, Candida, and even HPV, HSV-2, and HIV-1
[24-30]. Abnormal vaginal discharge may be the only
symptom of BV, and many affected women are asymp-
tomatic [31]. Zhou et al. have suggested that a certain
number of women without any symptoms do have vagi-
nal communities that resemble BV [13]. Previous studies
have demonstrated that BV is a polymicrobial syndrome,
characterized by a shift in vaginal microbiota from a
predominant population of Lactobacillus spp. [14,32] to
their gradual or total replacement with anaerobes such
as Gardnerella vaginalis [33], Morbiluncus spp. [34],
Prevotella spp. [14], Mycoplasma hominis [21] and the
recently identified metronidazole resistant Atopobium
vaginae [35]. These species are however also found in
subjects who do not suffer from BV with low copy num-
bers and thus cannot be used as a specific marker for
disease.
Because of our inability to cultivate most of the
microbial species that reside in the vagina, we have not
fully understood the taxonomic composition of the vagi-
nal microbiota, its community structure, and ultimately,
its function. With the advent of new molecular techni-
ques, we have been able to investigate bacterial diversity
in different microhabitats using molecular fingerprinting
methods and sequence analysis of microbial small subu-
nit ribosomal (r) RNA genes (16S rRNA) and other uni-
versal targets (such as cpn60) [13,36,37]. Among these
molecular fingerprinting methods, PCR-DGGE repre-
sents a rapid and reliable technique to identify the
predominant microbiota in various ecological niches
[38,39]. Sequencing of 16S rRNA genes from different
samples by constructing clone libraries, (typically at
most a few thousand clones from a low number of indi-
viduals), has revolutionized our understanding of micro-
bial systematics and diversity [40,41]. However, this
cloning and sequencing method identifies only the pre-
dominant microorganisms in a sample. Detection of
low-abundance taxa requires analysis of datasets that are
orders of magnitude larger than those currently available
[42]. The recently available high-throughput 454 pyrose-
quencing now allows for very in-depth sequencing and
analysis of microbial community composition, and also
allow for a dramatic increase in throughput via parallel
in-depth analysis of a large number of samples with lim-
ited sample processing and lower costs [43-45].This
technique has been successfully used in various ecosys-
tems including deep mines [46], soil [47], fermented
seafood [48], skin [49], chronic wounds [50], and oral
microbiota [42].
In order to better estimate the diversity of the vaginal
community of the healthy and BV positive women, and
to identify the key population changes relevant to BV
development, we first utilized PCR-DGGE with broad
range primers that correspond to the bacterial 16S
rRNA hypervariable V3 region to investigate the predo-
minant vaginal microbiota in these populations. We
then used massively parallel pyrosequencing, combined
with a DNA barcoding, to characterize the overall struc-
ture and composition of the vaginal bacterial commu-
nity in 50 BV and 50 CN (non-infected healthy women;
CN) individuals in China. We also quantified the abun-
dance of total Bacteria and bacterial subgroups that
associated significantly with BV using quantitative PCR
(qPCR). Our data provides a more comprehensive pic-
ture over current knowledge of the community structure
of the vaginal bacterial ecosystem. These results also
help to define the potential pathogenic populations in
BV and provide new insights into the etiology and treat-
ment of the disease.
Results
PCR-DGGE analysis of vaginal bacterial communities
PCR-DGGE is a useful tool to examine microbial diver-
sity and community structure in specific microhabitats
and has been widely applied for comparative analysis of
parallel samples. The differences of DGGE profiles in
the same community DNA samples might be caused by
different primer sets selected targeting the different
hypervariable regions of the 16S rRNA genes. The
hypervariable region(s) chosen for amplification can
influence the PCR-DGGE profiles and diversity indices
produced from community DNA samples, and even
subtle differences in primer sequences can result in
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ments of microbial diversity. By comparing different
hypervariable regions of 16S rRNA genes for PCR-
DGGE, Yu and Morrison (2004) have shown that the
DGGE profiles of the V3 region were the most reliable
[51]. As shown in Figure 1 A, the PCR-DGGE profiles
of BV and CN revealed significant differences in the
overall structure and composition of the vaginal com-
munity by targeting the V3 region of 16S rDNA. Bacter-
ial diversity was higher in the BV group than that in the
CN group. DGGE profiles were significantly different
from one another and varied with the participants. Fig-
ure 1 B depicts the results of Ward’sa n a l y s i si nw h i c h
the Dice coefficient for measuring similarity in banding
patterns was applied. The BV and CN groups displayed
a statistically significant clustering of profiles, cluster Ⅰ
(BV group) and cluster II (CN group). 11 dominant
fragments that could represent the pattern of the DGGE
profiles were excised from the DGGE lanes, reamplified,
sequenced and identified by BLAST with the 16S rRNA
V3 region sequences. Lactobacillus was the predominant
genus in the CN group and bacterial diversity of the BV
group was far more complex and was dominated by A.
vaginae, uncultured Sneathia sp., Fusobacterium nuclea-
tum subsp., uncultured Eggerthella sp., uncultured
Megasphaera sp., Clostridium acetobutylicum and Clos-
tridium thermocellum. From these results, we propose
that PCR-DGGE analysis could be used to monitor the
dramatic shift of bacterial transition and routinely
defined BV in laboratory.
Sequence analysis by pyrosequencing
From 50 BV and 50 CN individuals, more than 321,400
PCR amplicons of the V3 hyper-variable regions of the
16S rRNA gene were sequenced, of which a total of
246,359 pyrosequencing tags passed quality control,
and were included in our data analysis. Specifically, we
o b t a i n e d9 0 , 2 2 7s e q u e n c e sf r o mt h eB Vg r o u pa n d
156,132 sequences from the CN group respectively.
The average length of the sequences was 145 bp after
trimming the primers and the average number of
sequence reads was 2,464 per sample. The total num-
ber of unique sequences from the two groups was
24,298 and represented all phylotypes. It was unex-
pected that we obtained more sequences from CN
samples than from BV samples (p < 0.05, data not
shown) because the same amount of bacterial DNA
was used for preparing the library for pyrosequencing.
It can be assumed that the biased ratio of the two
groups was not only because of an inefficiency in the
emPCR technique for different species of vaginal bac-
teria, but also because of the impurities or unknown
compounds disturbing the accurate measurement of
DNA amount [48,52].
Figure 1 Figure 1 PCR-DGGE analysis of the predominant bacterial communities in vaginal swabs from bacterial vaginosis (BV group)
and healthy women (CN group). (A) Each lane of the PCR-DGGE gel represented one subject which was selected in its group at random. M
represents a marker constructed in this study with the identified bands to facilitate the interpretation of the figure. Bands: 1: Uncultured Sneathia
sp.; 2: Fusobacterium nucleatum subsp. nucleatum ATCC 25586; 3: Clostridium thermocellum ATCC 27405; 4: Lactobacillus iners; 5: Clostridium
acetobutylicum; 6: Lactobacillus iners; 7: Clostridium thermocellum ATCC 27405; 8: Atopobium vaginae; 9: uncultured Eggerthella sp.; 10:
uncultured Megasphaera sp.; 11: Lactobacillus crispatus. (B) Dendrogram of the DGGE profiles shown in panel A.
Ling et al. BMC Genomics 2010, 11:488
http://www.biomedcentral.com/1471-2164/11/488
Page 3 of 16The diversity of vaginal microbiota in BV and CN
individuals
The numbers of species detected in a sample, or the
numbers of organisms discerned at any given phyloge-
netic level, are strongly affected by the number of
sequences analyzed. Rarefaction analysis provides a
powerful method for evaluating the diversity and rich-
ness of different microhabitats in the human body. Rare-
faction curves were generated for unique, 1%, 2%, 3%,
5% and 10% sequence dissimilarities as described pre-
viously [47]. As shown in Figure 2, we found that there
was much more richness in bacterial diversity in BV
individuals than in CN individuals at the 3% dissimilar-
ity level. The number of OTUs continued to increase at
the 3% or 5% dissimilarity level in the BV group, how-
ever, the rarefaction curve in the CN group almost
reached the saturation level, which indicated that addi-
tional sampling was needed to determine the true
microbial diversity in the BV vaginal community. Based
upon the literature, the nonparametric ACE and Chao1
estimators are correlated positively with the number of
sequences analyzed [53] and overestimate the number of
species while the rarefaction estimator underestimates
the number of species at the 0% dissimilarity level.
However, the rarefaction estimator could accurately pre-
dict the number of species at the 3% dissimilarity level
and the number of genera at the 5% dissimilarity level.
For the two groups of vaginal communities analyzed at
the 3% dissimilarity level, the number of OTUs detected
was close to the total number of OTUs estimated by
Chao1 and ACE diversity indices, presenting additional
evidence that the natural communities were well cov-
ered during sequencing (Table 1). Good’s coverage was
more than 99.0% for all sequences in the two groups,
indicating that less than one additional phylotype would
be expected for every 100 additional sequenced reads.
This level of coverage indicated that the 16S rRNA
sequences identified in these groups represent the
majority of bacterial sequences present in the samples
under study. With the unique sequences analyzed, the
species diversity was evaluated with Shannon Index
(2.6133 in the CN group Vs. 3.7965 in the BV group)
and Simpson Index (0.3793 in the CN group Vs. 0.1240
in the BV group). So, the overall levels of bacterial
diversity was significantly different between the BV
group and the CN group (p < 0.05 for the two groups,
parametric ANOVA for Shannon and Simpson index)
(Figure 3), and bacterial communities were significantly
different between individuals from the two groups. The
vaginal community in the BV group (Evenness = 0.3327)
w a sm o r ee v e nt h a ni nt h eC Ng r o u p( E v e n n e s s=
0.2185) and indicated that bacterial community in the
BV group had greater species diversity. All these para-
meters corroborated each other and confirmed clearly
Figure 2 Rarefaction curves were used to estimate richness (in this case the number of taxa at a 3% dissimilarity level) among BV-
positive and BV-negative groups. The vertical axis shows the number of OTUs that would be expected to be found after sampling the
number of tags or sequences shown on the horizontal axis.
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positive women than in BV negative women. The sam-
ples in each group or in an individual sample were
divided into two clusters based on UniFrac metrics
(Figure 4), although there were few BV samples which
clustered in the CN group and vice versa. Although
more subclusters existed in the BV group, we found
that samples in the BV group formed a large cluster
that was very distinct from the CN group, which was
similar to the PCR-DGGE pattern, indicating that they
harbored quite different microbial communities.
The phylogenetic classification of sequences from the
vagina by phylum is summarized in Figure 5. The com-
position and relative abundance of the vaginal micro-
b i o t ab yp h y l u mm i g h tb en o th e l po n et ou n d e r s t a n d
the etiology of BV. However, it did reveal the overall
structure of the vaginal microbiota. Eight phyla were
found in the vaginal microbiota in women with or with-
out BV. Our data showed that the vast majority of
sequences belonged to one of the four major phyla:
Bacteroidetes, Firmicutes, Actinobacteria and Fusobac-
teria.O ft h e s em a j o rp h y l a ,Firmicutes was the most
dominant phyla in the vaginal microbiota of healthy
subjects, while bacteria belonging to Firmicutes, Bacter-
oidetes, Actinobacteria and Fusobacteria constituted the
complex vaginal microbiota in the BV group. The
remaining bacteria belonged to the phyla Chloroflexi,
Tenericutes, Proteobacteria and candidate division TM7
(around 0.1-1.0% of total sequences). The composition
of the vaginal microbiota at the phylum level was signifi-
cantly associated with BV by SPSS with One-Way
ANOVA (p< 0.001). At the genus level, sequences from
the two combined groups represented 116 different gen-
era, with 99 different genera in the BV group and 58
different genera in the CN group respectively (the tax-
onomy of the vaginal bacterial communities with RDP
classifier showed details in Additional file 1, Table S1).
Many genera found in the vaginal community were
unexpected, and our results suggest that this is one of
the most comprehensive investigations of vaginal micro-
biota conducted to date (Figure 6). Eleven genera
(Lactobacillus, Gardnerella, Atopobium, Megasphaera,
Eggerthella, Aerococcus, Alloiococcus, Streptococcus,
Leptotrichia/Sneathia, Prevotella and Papillibacter)c o n -
stituted more than 95% of the vaginal microbiota. Not
surprisingly, our study showed that the genus Lactoba-
cillus constituted the major proportion of vaginal micro-
biota in healthy women. This confirmed findings from
previous studies [13,14].
There was a significant difference between the BV and
CN group in all genera obtained from the vagina. The
abundance of Lactobacillus, Alloiococcus, Gardnerella,
Atopobium, Megasphaera, Eggerthella, Aerococcus,
Leptotrichia/Sneathia, Prevotella and Papillibacter was
Table 1 Comparison of phylotype coverage and diversity estimation of the 16S rRNA gene libraries at the 3%
dissimilarity from the pyrosequencing analysis
Group Reads OTUs
1 Good
2 ACE 95% C.I. Chao 95% C.I. Shannon Evenness
3 Simpson
BV-Negative 156,132 1,584 0.996 2,857 (2,714, 3,000) 2,500 (2,375, 2,625) 2.6133 0.2185 0.3793
BV-Positive 90,227 2,455 0.990 4,009 (3,808, 4,209) 3,694 (3,509, 3,879) 3.7965 0.3327 0.1240
1The operational taxonomic units (OTUs) were defined with 3% dissimilarity level.
2The coverage percentage (Good), richness estimators (ACE and Chao1) and diversity indices (Shannon and Simpson) were calculated using Good’s method
(Good, 1953) and the MOTHUR program.
3The Shannon index of evenness was calculated with the formula E = H/ln(S), where H is the Shannon diversity index and S is the total number of sequences in
that group.
Figure 3 Shannon index and Simpson index were used to estimate diversity (i.e., a combined assessment of the number of 1%
dissimilar bacterial taxa and their abundance) among the eight groups. Data shown as mean with SEM. There were significant differences
between BV-positive and BV-negative groups by parametric ANOVA.
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(Figure 7). This indicated that the composition and
abundance of the vaginal bacterial communities includ-
ing these genera played an important role in BV. At the
species level, defined as OTUs at the 3% dissimilarity
level, around 1,500 species and about 2,500 species were
found in the CN and BV group, respectively. While at a
more conservative level, defined as OTUs at the 5% dis-
similarity level, about 550 phylotypes in the CN group
and about 1,000 phylotypes in the BV group were
found. The two groups also shared a great degree of
community similarity in the vagina at the 3% dissimilar-
ity level–about 30% of the total phylotypes were present
in both groups (Figure 8). Our Venn diagrams agree
with previous findings that some genera in vaginal com-
munities were not specific for BV, but also existed in
the healthy women.
Total bacteria and species-specific qPCR
Our qPCR results supported the pyrosequencing results
in terms of which species were associated with BV,
although the relative abundance was not in concordance
(Additional file 2, Table S2). Consistent with previous
findings, we found that L. iners was a major component
of the vaginal microbiota in healthy women and
decreased markedly in BV subjects. Gardnerella, Atopo-
bium, Megasphaera, Eggerthella, Leptotrichia/Sneathia
and Prevotella were more common and present at a
higher copy numbers in the BV group, although there
were significant interpersonal variations (data not
shown). Our qPCR revealed the bacterial subgroups that
associated significantly with BV and verified the results
of PCR-DGGE and pyrosequencing data. Our quantita-
tive studies of the bacterial species in the vaginal com-
munities demonstrated one common finding: increased
numbers of these bacteria were found during the advent
of BV. Compared with vaginal microbiota in healthy
women, the relative abundance or copy numbers of
these bacteria combined with each other was associated
with BV significantly and could be potentially used as a
molecular marker of microbiota shift in vagina and as a
target for diagnosis of BV.
Figure 4 Differentiation in vaginal bacterial communities from 100 individual samples of BV-positive and BV-negative groups
(interpersonal variations). Community differentiation was measured by using the unweighted UniFrac algorithm; the scale bar indicates the
distance between clusters in UniFrac units. All of the branch nodes shown here were found to be significant (p< 0.001), indicating that BV-
positive and BV-negative harbored distinct bacterial communities.
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Page 6 of 16Figure 5 The relative abundance of vaginal bacterial V3 tags obtained by pyrosequencing from BV-positive and BV-negative
individuals, by phylum. Phylogenetic classification for the pyrosequencing analysis obtained from Ribosomal Database Project Classifier
analyses. The phyla of Firmicutes, Bacteroidetes, Actinobacteria, Fusobacteria were significant differences between BV-positive and BV-negative
groups by parametric ANOVA (p< 0.000).
Figure 6 The relative abundance of vaginal bacterial V3 tags obtained by pyrosequencing from BV-positive and BV-negative
individuals, by genus and profiled the overall structure of vaginal communities.
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Page 7 of 16Figure 7 Predominant genera detected in vagina from BV-positive and BV-negative individuals. Among these predominant genera,
Lactobacillus, Gardnerella, Atopobium, Alloiococcus, Sneathia, Prevotella, Papillibacter, Megasphaera, Eggerthella, Aerococcus were associated with BV
significantly (* p < 0.05, ** p < 0.01). Except for Lactobacillus and Alloiococcus, which were detected at a higher level, other genera were more
abundant in BV-positive individuals.
Figure 8 Venn diagrams for overlap between BV-positive observed OTUs versus BV-negative observed OTUs. The Venn diagrams show
the overlap in all OTUs calculated at the 3% dissimilarity level. The number of species in group BV-positive is 2,455. The number of species in
group BV-negative is 1,584. The number of species shared between groups BV-positive and BV-negative is 930. Percentage of species that are
shared in groups BV-positive and BV-negative is 29.91%.
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The bacterial diversity of vaginal microbiota was analyzed
by PCR-DGGE fingerprinting and barcoded pyrosequen-
cing. These phylotypes detected in the vagina matched
each other with two molecular analytical methods. PCR-
DGGE fingerprinting, which is a conventional molecular
ecological approach, only detected the predominant
microbiota (Lactobacillus, A. vaginae,u n c u l t u r e d
Sneathia sp., F. nucleatum subsp., uncultured Eggerthella
sp., and uncultured Megasphaera sp.) in the vagina, and
these phylotypes were also abundant in the 454 pyrose-
quencing reads. However, the bacterial communities
determined with the pyrosequencing analysis were more
diverse than those communities determined with the
PCR-DGGE analysis, as there were more phylotypes
revealed with the pyrosequencing analysis than with
PCR-DGGE fingerprinting. As we could not excise and
sequence all bands in the DGGE profiles, several domi-
nant bands were missed, of which might contain some
predominant bacteria such as G. vaginalis in the vaginal
communities. Pyrosequencingp r o v i d e dah i g h - t h r o u g h -
put approach to analyze the 16S rRNA gene sequences
and explore bacterial diversity in different microhabitats
deeply, which can compensate for the disadvantage with
the PCR-DGGE method in detecting minor populations
in microbiota. As only predominant microbiota could be
detected by PCR-DGGE, band richness could not reveal
the overall extent of bacterial diversity in the vagina.
With clustering analysis using the UniFrac algorithm, we
found similar cluster profiles in the two groups. The sam-
ples in the BV and CN group were divided into two clus-
ters respectively (Figure 1B and Figure 4). To analyze
bacterial diversity, PCR-DGGE fingerprinting and high-
throughput pyrosequencing were two important and use-
ful methods, which could corroborate one another.
Discussion
An understanding of the composition and richness of
the vaginal microbial ecosystem in relation to vaginal
health is essential for comprehensively understanding
the etiology of vaginal diseases, and for the prevention
and treatment of these diseases. We analyzed the vaginal
communities of healthy participants and women with
clinically defined BV which was diagnosed by Amsel cri-
teria and clearly confirmed by Nugent criteria with
Nugent score ≥ 7. Indeed, few of these subjects were
asymptomatic BV, where the shift of vaginal microbiota
has occurred but the symptoms are absent. However,
both the Gram staining and PCR-DGGE verified our
diagnosis. Although there are several previous studies
that focus on the vaginal microbiota in health and dis-
ease or in different races, molecular analysis such as the
broad-range PCR assays, terminal restriction fragment
length polymorphisms (T-RFLPs) and PCR-clone library
analysis still cannot demonstrate the overall structure
and composition of vaginal microbiota comprehensively
[13,14,54]. In fact, the depth of the bacterial diversity in
a specific microhabitat is strongly influenced by the
total number of sequences that are used for analysis
[47]. These previous studies obtained only hundreds of
reads for each sample which severely limited the depth
of understanding of the overall structure of vaginal
microbiota. However, pyrosequencing of the 16S rRNA
gene amplicons for microbial community profiling can,
for equivalent costs, yield more than two orders of mag-
nitude more sensitivity than traditional PCR cloning and
Sanger sequencing [55]. In our study, multiplex bar-
coded pyrosequencing analysis enabled us to analyze an
increased number of samples at a time, to obtain more
reads in a single run, to monitor the sequencing error
rate, and to perform in-depth analyses for studies of
comparative microbial ecology. Although the pyrose-
quencing read lengths of the sequences were signifi-
cantly short compared with the sequences obtained with
traditional Sanger sequencing methods (600-800bp),
these short sequences (about 145bp in our study) pro-
vided not only excellent coverage but also excellent
recovery for classification at the genus level [56]. In
addition, the 145bp in the highly variable region V3 of
the 16S rRNA gene had good discerning power (pro-
v i d e dt h a ta1 b pd i f f e r e n c ei nt h e1 6 Sr R N Ag e n e
sequences differentiated the reads by 0.55% for bacteria)
and were long enough to be sufficient for assigning the
taxa [48]. Engelbrektson et al. (2010) have shown that
f o rag i v e nn u m b e ro fr e a d s ,s h o r t e r1 6 Sr R N Ag e n e
amplicons yield greater species richness than do longer
amplicons. Approximately 100bp amplicons produced
significantly higher estimates of richness than 400bp or
1,000bp products did [57]. All indicated that multiplex
parallel pyrosequencing offered a highly automated,
rapid, economical and accurate method for the analysis
of bacterial diversity. Our study represents one of the
most extensive investigations of bacterial diversity in the
vagina.
With 454 pyrosequencing analysis, we found that the
vaginal bacterial diversity in participants with BV was
remarkably high and much greater than previously
reported with culture-independent approaches such as
PCR-DGGE and cloning and sequencing [13,14,37,
39,58] and similar with the deep-sequencing techniques
by Spear et al. (2008) [59]. The higher number of phylo-
types in BV positive women over healthy was consistent
with the results of previous studies, and most of which
were previously uncultivated species and undiscovered
novel phylotypes in the vagina. Compared with other
molecular methods for microbiota diversity analysis
such as cloning and sequencing approaches, we
observed higher bacterial diversity by high-throughput
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than 99.0%) [13,54,60]. The rarefaction curves were still
not saturated at the 3% dissimilarity level even if more
than 150,000 sequences in the CN group were retrieved,
which indicated that more sequencing effort should be
undertaken to obtain the saturation of the curves. How-
ever, the Good’s coverage of more than 99.0% of our
study showed that we had obtained almost all bacterial
species in the vaginal communities. Recently, a compu-
tational model revealed that more than 9 million unique
genes were likely to be present in the human gut bacter-
ial community. It was far more rich than had been
expected [61]. Based on more pyrosequencing reads and
good coverage, that’s why the depth of the vaginal com-
munities in our study was superior to those previous
studies [13,14,54,58,59]. Other diversity indices shown
in Table 1, such as Shannon index, Chao1 and ACE,
were also higher in the BV group than in the CN group
at the same dissimilarity level. Furthermore, for each
sample analyzed in our study, these diversity indices
showed significantly interpersonal variations even in the
same group (data not shown), similar to that observed
for the gastrointestinal tract and human skin [40,62,63].
The variation might be due to hormone levels, personal
hygiene behavior and even diet [64-66]. Although there
were pronounced interpersonal variations in the bacter-
ial community composition of the vagina, the partici-
pants also shared a great degree of community similarity
in each group and the overall structure of the vaginal
bacterial communities in the two groups was obviously
divided into two clusters.
Our study represents one of the most extensive exam-
inations of bacterial diversity in the vagina. We demon-
strated in this research that BV was associated with
compositional changes in the vaginal microbiota mostly
apparent at high taxonomic level (phylum) and even
genus level. From the eight phyla that we observed in
the vaginal ecosystem, Firmicutes constituted the vast
majority of vaginal microbiota in healthy women, while
Bacteroidetes, Actinobacteria and Fusobacteria were
strongly associated with BV. It is not surprising that the
predominant bacterial populations in the healthy vagina
contained lactic acid bacteria (mainly the genus of Lac-
tobacillus) [67] because these genera can maintain a low
vaginal pH through their metabolic activity and thereby
play a role in colonization resistance providing protec-
tion against invasion by overt pathogens or against over-
growth and dominance by potentially pathogenic species
among the normal microbiota [68-70]. However, the
genera of Alloiococcus (member of the lactic acid bac-
teria), which was previously an unrecognized common
member of the healthy vaginal ecosystem, was detected
more frequently as normal microbiota in the healthy
women in our study. Our data firstly indicated that the
members of Alloiococcus along with members of the
Lactobacillus might contribute to maintaining the bal-
ance of the healthy vaginal ecosystem. Extensive diver-
sity within the Lactobacillus species complex of the
vagina has been observed in previous studies. With spe-
cies-specific qPCR, we also found that L. iners was one
of the most abundant vaginal Lactobacillus species in
healthy women, while about 100 to 1000-fold copies
declined or were even absent in the subjects with BV.
Research has shown that L. iners is a dominant part of
the vaginal microbiota when in a transitional stage
between abnormal and normal health, either because of
treatment or because of physiological changes such as
varying estrogen levels [71,72]. As a result, L. iners
could be considered as even more typical for normal
vaginal microbiota and be a sensitive marker of changes
in the vaginal microbiota. Other species of Lactobacillus
such as L. crispatus and L. jensenii were also commonly
detected Lactobacillus species in the vaginal microbiota
but at a lower relative abundance. Previously, L. crispa-
tus has been suggested to be more often linked with
health and L. iners with disease [72]. However, no clear
quantitative support was found for this claim in our
study.
The onset of BV is marked by a decline in the Lactoba-
cillus species and other facultative or anaerobic species as
the vaginal microbial ecosystem changes from eubiosis to
dysbiosis [73]. In our study, eight BV-related genera, i.e.,
Gardnerella, Atopobium, Megasphaera, Eggerthella, Aero-
coccus, Leptotrichia/Sneathia, Prevotella and Papillibacter,
were detected at higher prevalence and higher relative
abundance in women with BV. These genera included
pathogenic species that participated in BV progression.
Previous studies have shown that G. vaginalis (belonging
to Actinobacteria), was found in most subjects with BV
and showed higher sensitivity for the diagnosis of BV
[14,33,74], but our data also found this species in subjects
with low abundance level who did not have BV. This sug-
gests that this species cannot be used as a specific marker
for this disease. The difference might be associated with
the depth of the pyrosequencing method. Despite its non-
specific discrimination between BV and CN, we did
observe that it was one of most important species in the
vaginal communities that associate with BV. Another
genus in Actinobacteria, Atopobium, which plays an
important role in the development of BV and treatment
failure, is highly abundant in the vaginal microbiota of BV
[35]. Our pyrosequencing study showed that Atopobium is
present in a significant proportion (84%) of women clini-
cally diagnosed as having BV, but in only 22% women in
CN group (p < 0.05). Although Atopobium was also a lac-
tic acid bacterium, its cellular morphology and role was
distinctly different from that of Lactobacillus [75]. With
this aspect, Bradshaw et al. (2006) suggested that
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(77% and 35%, respectively) [76]. Our results also con-
firmed this implication. Eggerthella, like A. vaginae in this
phylum, was strongly correlated with BV. Tamrakar et al.
(2007) reported that the presence of Eggerthella was an
independent risk factor of BV scores (Nugent score ≥ 7)
[77]. In our study, we highlighted this genus in the vaginal
bacterial community in the process of BV. Many studies
have shown that Mobiluncus (belonging to Actinomyceta-
ceae in the phylum of Actinobacteria) was found in vaginal
bacterial communities only when BV was present, and had
a high-level resistance to metronidazole [78]. However, we
obtained only low abundance of this genus in our study,
which was consistent with a previous study [60]. Other
members of the Firmicutes, Megasphaera (especially
Megasphaera typeⅠ), Aerococcus and Papillibacter,w e r e
also associated with BV significantly, although these gen-
era could not be detected in all BV samples. However, the
clinical significance of these genera in the vaginal ecosys-
tem is still unknown. Previous work has shown that Mega-
sphaera typeⅠ appeared to have a stronger association
with BV than type Ⅱ [79]. We also found that Mega-
sphaera typeⅠwas common in BV patients and those two
unfamiliar genera of Aerococcus and Papillibacter in vagi-
nal bacterial communities were obviously correlated with
BV for the first time. Prevotella (belonging to Bacteroi-
detes), one of the recently identified predominant micro-
biota in the complex vaginal communities of BV subjects,
was significantly associated with BV in our qPCR and pyr-
osequencing studies (p < 0.05). Prevotella was dramatically
higher (7 orders of magnitude) in almost all patients with
the clinically defined BV in our qPCR experiment. Our
data showed that Prevotella spp. were more common and
abundant than other BV-associated genera in the vagina.
Ammonia flow from Prevotella to G. vaginalis has been
demonstrated and a commensal relationship proposed
[80]. It might be implicated that Prevotella showed a
synergistic effect with G. vaginalis and aggravated the pro-
cess of BV. The combination of bacterium-specific PCR
assays for Prevotella and G. vaginalis might improve sensi-
tivity or specificity for the diagnosis of BV. Leptotrichia/
Sneathia (belonging to Fusobacteria), which was also a
lactic acid-producer, was strongly associated with BV in
our study. However, there was little known about the ecol-
ogy of this genus. Fredricks et al. (2005) showed that
detection of Leptotrichia species was very specific for BV
by bacterium-specific PCR assays [14]. Our observations
in qPCR and pyrosequencing studies showed that the pre-
valence of Leptotrichia/Sneathia in BV patients was higher
than in CN subjects. It could be a new marker of BV in
the pathogenic vaginal communities like others mentioned
above. Compared with the ten predominant genera, other
bacteria identified from the complex vaginal bacterial
communities were detected at low relative abundance.
Some have been detected in the vagina before, but most of
them were first found in our study.
H o w e v e r ,t h e r ew e r ea l s os ome limitations to our
study. First, there was no analysis of Nugent score and
pH in relation to the change of vaginal community
structure and composition as participants diagnosed as
BV in our study were almost with Nugent score ≥ 7 and
ap Ho fv a g i n a ld i s c h a r g e≥ 4.5. For such an analysis it
would be necessary to explore the relationship between
intermediate vaginal microbiota (4 ≤ Nugent score < 7)
and asymptomatic BV. Second, we did not explore the
dynamics of vaginal bacterial communities in the pro-
cess of BV and the bacterial diversity for re-establish-
ment of vaginal microbiota after effective treatment by
the high-throughput pyrosequencing. Further studies of
the vaginal microbiota-host interplay, especially those
bacteria found in our study with low relative abundance
and its influence on local vaginal immunity, will be
necessary in order to understand extensively the ecologi-
cal role of the complex vaginal bacterial communities in
the BV process. This new insight into the overall struc-
ture of vaginal community in BV may provide funda-
mental information for future investigations.
Conclusions
Our results elucidated that vaginal microbiota are more
diverse in BV participants than we expected before.
This provides novel insights into the vaginal microbiota
in the etiology of BV and confirms that the barcoded
pyrosequencing approach can be a powerful tool for
characterizing the microbiota in vaginal ecosystems
compared with classical molecular ecological
approaches, such as PCR-DGGE. The study represents
one of the most extensive examinations of bacterial
diversity in the vagina. We observed that at a high taxo-
nomic level, the phylum of Bacteroidetes, Actinobacteria
and Fusobacteria were significantly associated with BV.
Although no single bacterium can be identified as
uniquely associated with BV, our data indicated that the
vaginal communities including Gardnerella, Atopobium,
Megasphaera, Eggerthella, Aerococcus, Leptotrichia/
Sneathia, Prevotella and Papillibacter were clearly asso-
ciated with BV. These genera in the vaginal commu-
nities were potentially excellent markers of BV and
could be used as targets for BV diagnosis by molecular
approaches alone or in combination. Our results have
provided a comprehensive picture of our current knowl-
edge of the community structure of the vaginal bacterial
ecosystem and have significantly increased current
understanding of the etiology of BV. Continuing
exploration of vaginal bacterial communities and host
interplay in different healthy and diseased states will
shed light on the BV susceptibility and provide new
insights for treatment.
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Subject Selection
One hundred women with regular menstrual cycles (24-
35 days) aged 19 to 51 years, including 50 BV positive
women (BV group, aged 33.3 ± 9.1) and 50 healthy con-
trol women (CN group, aged 32.0 ± 8.1), who came to
the Department of Obstetrics and Gynecology of the
First Affiliated Hospital, College of Medicine, Zhejiang
University for routine gynecology examination from
October 2008 to May 2009, were recruited for this
study. Informed written consent was obtained from all
participants prior to enrollment, with approval of the
ethical committee of the First Affiliated Hospital,
College of Medicine, Zhejiang University, Zhejiang pro-
vince, China. Individuals who participated in this study
were examined by two gynecologists. BV status was
assessed using Amsel clinical criteria for all subjects [81]
and confirmed using Gram stain criteria (Nugent scores)
[82]. Only participants with Nugent score ≥ 7w e r e
selected for the following analysis. Any participant hav-
ing any of the following exclusion criteria was excluded
from participation: <18 years of age, pregnancy, diabetes
mellitus, the use of antibiotics or vaginal antimicrobials
(orally or by topical application in vulvar/vaginal area)
in the previous month, menstruation, presence of an
intrauterine device, vaginal intercourse within the latest
3 days, known active infection due to Chlamydia, yeast,
N. gonorrhoeae,o rT. vaginalis, clinically apparent
herpes simplex infection, or defined diagnosed HPV,
HSV-2, or HIV-1 infection. (The clinical data for each
participant were shown in Additional file 3, Table S3).
The participants who met three or more of the follow-
ing criteria were clinically diagnosed as BV: homogenous
vaginal discharge, >20% clue cells on wet mount,
elevated pH (≥4.5) of vaginal discharge, and release of a
fishy amine odor upon addition of 10% potassium
hydroxide solution to vaginal fluid ("whiff” test) [81].
Then based on the criteria for BV assessment developed
by Nugent et al. [82], participants with the Gram stain
score of ≥7 were finally confirmed as BV. Participants
without these changes were defined as the healthy con-
trol group.
Sample Collection and Preparation
When women underwent genital examination, 2 swabs
from each woman were taken near the mid-vagina using
a sterile swab, packaged and placed in ice packs. (Kim et
al. (2009) [83] have revealed that the vaginal microbiota
is not homogenous throughout the vaginal tract but dif-
fers significantly within an individual with regard to ana-
tomical site and sampling method used.) The first swab
was rolled onto a slide for Gram staining; the second
vaginal swab was used for bacterial genomic DNA
extraction. The vaginal swabs for bacterial genomic
DNA extraction were transferred to the laboratory
immediately in an ice-box, and stored at -80°C after pre-
paration within 15 min for further analysis.
Total bacterial genomic DNA extraction
The bacterial cells retrieved on swabs were submerged
in 1 ml of sterile normal saline (prepared with RNase
free H2O, pH 7.0) and vigorously agitated to dislodge
cells. The cells were pelleted by centrifugation (Thermo
Electron Corporation, Boston, MA, USA) at full speed
(≥ 10,000 g) for 10 min, washed by re-suspending cells
in sterile normal saline and centrifuged at full speed for
5 min. Then bacterial DNA was extracted from the vagi-
nal swabs using QIAamp DNA Mini Kit (QIAGEN, Hil-
den, Germany) according to manufacturer’s instructions
with minor modification. Briefly, the bacterial pellet was
suspended in 180 μl of lysis buffer (buffer ATL) and
homogenized by vortexing. A total of 20 μlo fap r o t e i -
nase K solution (20 mg/ml) and 100 mg of zirconium
beads (0.1 mm) were then added. The mixtures were
agitated in a mini bead beater (FastPrep, Thermo Elec-
tron Corporation, USA) three times, 40 s each time, and
incubated at 56°C for approximately 40 min. 200 μlo f
the second lysis buffer (buffer AL) provided in the kit
was added, and the sample was incubated at 70°C for
10 min. Next, 200 μl of ethanol was added; this mixture
was then loaded on the QIAamp spin column and cen-
trifuged at 8,000 g for 1 min. The QIAamp spin column
was placed in a new 2 ml collection microtube, and the
containing filtrate was discarded. The column material
was washed with 500 μl buffer AW1 and with 500 μl
buffer AW2 provided in the kit. Finally, the DNA was
eluted with 20 μl of distilled water (2 × 10 μl). The con-
centration of extracted DNA was determined by using a
NanoDrop ND-1000 spectrophotometer (Thermo Elec-
tron Corporation, USA); its integrity and size were
checked by 1.0% agarose gel electrophoresis containing
0.5 mg/ml ethidium bromide. All DNA was stored at
-20°C before further analysis.
PCR-DGGE analysis
Universal bacterial primers 341F and 534R for the V3
regions of 16S rRNA genes were used to amplify
approximately 200 bp, based on positions 341 to 534 of
the Escherichia coli 16S rRNA gene, as described by
Muyzer et al. (1993) [38,51]. The reaction conditions
were those as described previously by Li et al. (2008)
[41] with minor modifications. The DGGE analysis
(with 35% to 50% gradient) and the sequence analysis of
the excised DGGE bands was performed as described
[41]. The similarities of PCR-DGGE DNA profiles were
analyzed with Quantity One® 1-D Analysis software
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A similarity matrix was constructed using Dice’s similar-
ity coefficient. A dendrogram was constructed by the
unweighted pair group method, using arithmetic
averages (UPGMA) (details in Additional file 4, Supple-
mentary Information).
454 pyrosequencing and data analysis
PCR amplification of the 16S rRNA gene hypervariable
V3-region was performed with universal bacterial pri-
mers (It must be noted that 454 adaptor sequences and
barcodes are not shown here): 341F (5’- ATTACCGC
GGCTGCTGG -3’) and 534R (5’-CCTACGGGAGG-
CAGCAG -3’) (details in Additional file 4, Supplemen-
tary Information) as described [48]. Amplicon
pyrosequencing was performed with standard 454/Roche
GS-FLX protocols [84]. After pyrosequencing, all reads
were screened and filtered for quality and length using
customized Perl scripts written by ourselves. Raw
sequences were processed and analyzed following the
procedure described previously [43]. Approximately
23.3% of the total raw pyrosequencing reads was not
passed quality control. Sequences were assigned to sam-
ples by examining the 8-bp barcode (Additional file 5,
Table S4) [85]. The qualified 16S rRNA gene fragments
were processed as previously described [86]. OTUs and
OTU rarefaction curves were created by aligning unique
tag sequences and used to determine richness and diver-
sity indexes (Shannon Weaver and Simpson diversity
indices), ACE, Chao1, Good’s coverage at each dissimi-
larity level using MOTHUR (version 1.5.0) http://
schloss.micro.umass.edu/[87]. Read level taxonomic
assignments were performed using the Ribosomal Data-
base Project (RDP) Classifier program http://rdp.cme.
msu.edu/[88] with an 80% bootstrap score. Community
comparative analysis was performed using the web-
based service UniFrac [89]. The neighbor-joining tree
was constructed using the MEGA 4.0 program based on
the Jukes-Cantor model and used for UniFrac analysis.
The statistical significance of differences in microbial
community composition, and Shannon and Simpson
index between sample categories was determined by
SPSS with One-Way ANOVA (details in Additional file
4, Supplementary Information).
Validation of the relative abundance of vaginal
microbiota with qPCR
To estimate the accurate copy numbers of total Bacteria
and bacterial subgroups in the samples, and to validate
the relative abundance of genus-specific bacteria as
determined by 454 pyrosequencing. 16S rRNA gene-tar-
geted qPCR (species-specific primers in Additional file
6, Table S5) was performed with a Power SYBR Green
PCR Master Mix (Takara, Dalian, China) on an ABI
7900 Real-time PCR instrument according to the manu-
facturer’s instructions (Applied Biosystems, Foster city,
CA). Details of the standards and PCR conditions
are provided in Additional file 4, Supplementary
Information.
Additional material
Additional file 1: Table S1. The taxonomy of vaginal bacterial
communities with RDP Classifier. Taxonomic assignments at the genus
level were made with a bootstrap confidence range at ≥ 80% using the
RDP Classifier.
Additional file 2: Table S2. The abundance of vaginal bacteria
relative to total Bacteria gene copy number by species-specific
qPCR. Comparisons of the relative abundance of the specific bacteria in
the vagina between women with BV and women without BV were
calculated with independent-samples T-tests (SPSS Data Analysis Program
version 16.0, SPSS Inc, Chicago, IL) and were considered statistically
significant if p < 0.05. These qPCR results supported the pyrosequencing
results in terms of which species were associated with BV, although the
relative abundance was not in concordance.
Additional file 3: Table S3. The Clinical Data for Each Participant.
100 subjects (50 women with BV and 50 women without BV) that
participated in our study were diagnosed with Amsel clinical criteria and
Nugent criteria.
Additional file 4: Supplementary Information. Supplemental materials
and methods used in our study.
Additional file 5: Table S4. List of the 100 8-bp barcodes used to
tag each PCR product analyzed as part of the study. Table of 8-bp
barcodes used to identify each sample from the sample pool.
Additional file 6: Table S5. Species-specific primer sets for detection
of vaginal bacteria by qPCR. Table of primers used in this study to
carry out real-time PCR analysis of total bacteria and 10 bacterial species
in the vagina.
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